These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30742979)

  • 21. Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease.
    Stein RE; Plantz K; Maxwell EC; Mamula P; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2018 Feb; 66(2):e51-e55. PubMed ID: 28704225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A robust and easily reproducible protocol for the determination of size and size distribution of iron sucrose using dynamic light scattering.
    Di Francesco T; Borchard G
    J Pharm Biomed Anal; 2018 Apr; 152():89-93. PubMed ID: 29414023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical nanomaterial attributes of iron-carbohydrate nanoparticles: Leveraging orthogonal methods to resolve the 3-dimensional structure.
    Krupnik L; Joshi P; Kappler A; Flühmann B; Alston AB; Digigow R; Wick P; Neels A
    Eur J Pharm Sci; 2023 Sep; 188():106521. PubMed ID: 37423578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Core size determination and structural characterization of intravenous iron complexes by cryogenic transmission electron microscopy.
    Wu Y; Petrochenko P; Chen L; Wong SY; Absar M; Choi S; Zheng J
    Int J Pharm; 2016 May; 505(1-2):167-74. PubMed ID: 27001529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin.
    Anbu AT; Kemp T; O'donnell K; Smith PA; Bradbury MG
    Acta Paediatr; 2005 Dec; 94(12):1738-41. PubMed ID: 16431410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single dose of intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of postoperative anaemia in colorectal cancer patients: study protocol for a randomised controlled trial.
    Laso-Morales MJ; Vives R; Vallejo-Tarrat A; Caló N; Valle-Beltran A; Pontes C
    Trials; 2019 Jan; 20(1):23. PubMed ID: 30616657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients with severe anemia, iron deficiency and chronic kidney disease.
    Schwenk MH; Blaustein DA
    Clin Nephrol; 2004 Aug; 62(2):116-20. PubMed ID: 15356968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic Light Scattering Analysis for the Determination of the Particle Size of Iron-Carbohydrate Complexes.
    Burgert M; Marques CB; Borchard G; Philipp E; Wilhelm M; Alston A; Digigow R
    J Vis Exp; 2023 Jul; (197):. PubMed ID: 37486118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue biodistribution of intravenous iron-carbohydrate nanomedicines differs between preparations with varying physicochemical characteristics in an anemic rat model.
    Funk F; Weber K; Nyffenegger N; Fuchs JA; Barton A
    Eur J Pharm Biopharm; 2022 May; 174():56-76. PubMed ID: 35337966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: A systematic review.
    Qassim A; Mol BW; Grivell RM; Grzeskowiak LE
    Aust N Z J Obstet Gynaecol; 2018 Feb; 58(1):22-39. PubMed ID: 28921558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.
    Pai AB
    Ann N Y Acad Sci; 2017 Nov; 1407(1):17-25. PubMed ID: 29027212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intravenous iron, functional recovery and delirium in patients with hip fracture. FEDEREF study. Single-centre randomised, placebo-controlled, and double-blind clinical trial. 2014-001923-53: EudraCT number].
    Bielza Galindo R; Llorente Gutiérrez J; Pérez González JL; Mora Casado A; Blanco Díaz D; Escalera Alonso J; Morales Fernández A; Molano Ortiz C; García López BE; Del Amo Del Arco N; Barro Ordovas JP; Arias Muñana E; Neira Álvarez M; Sanz Rosa D; Gómez Cerezo JF
    Rev Esp Geriatr Gerontol; 2018; 53(1):38-44. PubMed ID: 28292532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo.
    Kosch M; Bahner U; Bettger H; Matzkies F; Teschner M; Schaefer RM
    Nephrol Dial Transplant; 2001 Jun; 16(6):1239-44. PubMed ID: 11390726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study.
    Ikuta K; Hanashi H; Hirai K; Ota Y; Matsuyama Y; Shimura A; Terauchi M; Momoeda M
    Int J Hematol; 2019 Jan; 109(1):41-49. PubMed ID: 30039442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
.
    Macdougall IC; Strauss WE; Dahl NV; Bernard K; Li Z
    Clin Nephrol; 2019 Apr; 91(4):237-245. PubMed ID: 30802204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients.
    Nguyen TV
    Am J Health Syst Pharm; 2009 Jun; 66(12):1101-4. PubMed ID: 19498125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications.
    Jahn MR; Andreasen HB; Fütterer S; Nawroth T; Schünemann V; Kolb U; Hofmeister W; Muñoz M; Bock K; Meldal M; Langguth P
    Eur J Pharm Biopharm; 2011 Aug; 78(3):480-91. PubMed ID: 21439379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated cardiac troponin T in hemodialysis patients receiving more intravenous iron sucrose.
    Guz G; Sahinarslan A; Dhondt AW; Bagdatoglu O; Kavutcu M; Reis KA; Yalçin R; Bali M; Sindel S
    Ren Fail; 2004 Nov; 26(6):663-72. PubMed ID: 15600258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicines and Nanosimilars: Looking for a New and Dynamic Regulatory "Astrolabe" Inspired System.
    Demetzos C; Kavatzikidou P; Pippa N; Stratakis E
    AAPS PharmSciTech; 2020 Jan; 21(2):65. PubMed ID: 31933006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physicochemical Characterization of Iron Carbohydrate Colloid Drug Products.
    Zou P; Tyner K; Raw A; Lee S
    AAPS J; 2017 Sep; 19(5):1359-1376. PubMed ID: 28762128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.